PORT WASHINGTON, N.Y., April 15, 2015 - First paragraph, second sentence of release should read: The dividend is payable on May 8, 2015 to shareholders of record on the close of business on April 25, 2015 (instead of: The dividend is payable on May 8, 2015 to shareholders of record on the close of business on April 24, 2015).

 

The corrected release reads:

 

PALL CORPORATION BOARD OF DIRECTORS DECLARES DIVIDEND

 

Pall Corporation (NYSE:PLL) today announced that its board of directors declared a quarterly dividend of $0.305 per share. The dividend is payable on May 8, 2015 to shareholders of record on the close of business on April 25, 2015.

 

About Pall Corporation

 

Pall Corporation (NYSE:PLL) is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The company’s engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation is an S&P 500 company serving customers worldwide. Follow us on Twitter @PallCorporation or visit www.pall.com.

R. Brent Jones
Pall Corporation
Senior Vice President
Corporate Development & Treasurer
516.801.9871
or
Jim Conenello
Director
Investor Relations & Corporate Communications
516.801.9871
Follow us on Twitter @Pallcorporation

More Pall Corporation Press Releases
July 2019
July 16, 2019: Servier chooses Pall as exclusive technology and services provider for planned Bio-S biomanufacturing facility in France
April 2019
April 29, 2019: Freeline's (AAV) manufacturing platform and Pall’s iCELLis bioreactor system combine to achieve commercial-scale and high quality production of AAV gene therapy vectors
March 2019
March 19, 2019: New lab will serve as a dedicated platform where the industry can access shared resources including equipment, expertise and project work to find innovative solutions to manufacturing needs for biologic medicines, such as cell-based immunotherapies
March 13, 2019: Pall Biotech to distribute ARTeSYN’s standard hardware and liner components for fluid flow control. Customers to benefit from the flexibility, agility and reliability required for their bioprocessing journey, with accelerated implementation of robust and standardized single-use fluid management and control
March 11, 2019: Pall Biotech to integrate and distribute Broadley-James’ advanced single-use probe and flow cell pH sensors; sensor will be integrated into Pall Biotech’s single-use technologies
March 1, 2019 - Pall Corporation Obtains FAA PMA Approval and extends its Advanced Cabin Air Filters (A-CAF) product line to Boeing.
December 2018
December 18, 2018: New centre to give Pall customers options ranging from batch to single use and continuous bioprocessing solutions, and to provide technology solutions that meet current needs, while offering some of the most progressive technological solutions for the future
November 2018
November 26, 2018: Cobra and Pall to make commercialisation of gene therapies safer, faster, and cheaper than ever before, help increase patient access to gene therapy and further establish best practices in manufacturing
October 2018
October 2, 2018: New centre will work to enhance drug production and empower the future workforce, reinforcing Pall's commitment to continuously improve bioprocesses through strategic partnerships
September 2018
September 24, 2018: New collaboration to see G-CON PODs customized with Pall technologies, addressing customer demand for higher efficiencies, while enjoying more flexibility through scale-out and localization of manufacturing